(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IQIRVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IQIRVO

ST13

US500000079385969

Class

5

Filing

79385969

Registration

7540092

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

04/03/2026

Trademark type

Combined

Nice classes

5

Filing date

10/05/2023

Registration date

10/22/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/22/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

33

Owner location

FR

Examiner

GUROK, GALINA

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "IQIRVO" with the letters "IQIR" and "O" in purple and the letter "V" formed by three blue parallel lines with a purple shadow in the lower left portion.

Holders and representatives

Holders

GENFIT

Representatives

Ronald M. Kachmarik Cooper Legal Group, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary productspharmaceutical and veterinary preparations for prevention and treatment of liver diseasesmetabolic diseasesgastroenterological diseasesinflammatory diseasesimmune disorders and cancers; chemical preparations for medical or pharmaceutical usechemical reagents for medical or pharmaceutical usediagnostic preparations for medical usediagnostic testing agents and substances for medical use

Publications

History of USPTO decisions and trademark events.

27 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/27/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/19/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/20/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/20/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/19/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/29/2025

FIMP

FINAL DISPOSITION PROCESSED

03/29/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/22/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/22/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/22/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2024

PUBO

PUBLISHED FOR OPPOSITION

08/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/17/2024

RFNT

REFUSAL PROCESSED BY IB

07/15/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/28/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/28/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/28/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/26/2024

RFRR

REFUSAL PROCESSED BY MPU

06/26/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/14/2024

CNRT

NON-FINAL ACTION WRITTEN

05/29/2024

DOCK

ASSIGNED TO EXAMINER

05/24/2024

MAFR

APPLICATION FILING RECEIPT MAILED

01/23/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/17/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/02/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/21/2023

Continuous trademark protection

Get notified about every new filing that threatens IQIRVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.